ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05167	Kaposi's sarcoma-associated herpesvirus infection	6/24	191/7206	2.89721013767e-05
ko04932	Non-alcoholic fatty liver disease (NAFLD)	5/24	182/7206	0.000279802257423
ko04380	Osteoclast differentiation	4/24	134/7206	0.000909973641833
ko05160	Hepatitis C	4/24	153/7206	0.00149084714767
ko05164	Influenza A	4/24	167/7206	0.00205789785258
ko05212	Pancreatic cancer	3/24	83/7206	0.00250465584631
ko04217	Necroptosis	4/24	178/7206	0.00259753277559
ko05168	Herpes simplex infection	4/24	182/7206	0.00281590465778
ko05100	Bacterial invasion of epithelial cells	3/24	99/7206	0.00412902710774
ko04620	Toll-like receptor signaling pathway	3/24	100/7206	0.00424745812891
ko05162	Measles	3/24	120/7206	0.0070623606327
ko04668	TNF signaling pathway	3/24	120/7206	0.0070623606327
ko04666	Fc gamma R-mediated phagocytosis	3/24	122/7206	0.00739221085526
ko04211	Longevity regulating pathway	3/24	123/7206	0.00756053269134
ko04630	Jak-STAT signaling pathway	3/24	132/7206	0.00917868600653
ko04130	SNARE interactions in vesicular transport	2/24	44/7206	0.00923518809687
ko04933	AGE-RAGE signaling pathway in diabetic complications	3/24	135/7206	0.0097599212609
ko04931	Insulin resistance	3/24	137/7206	0.0101591891882
ko04215	Apoptosis - multiple species	2/24	47/7206	0.0104892106965
ko04810	Regulation of actin cytoskeleton	4/24	264/7206	0.010490405841
ko05203	Viral carcinogenesis	4/24	277/7206	0.0123641660117
ko04014	Ras signaling pathway	4/24	279/7206	0.0126704603473
ko04670	Leukocyte transendothelial migration	3/24	151/7206	0.0132218995936
ko04621	NOD-like receptor signaling pathway	3/24	157/7206	0.0146801322989
ko05166	HTLV-I infection	4/24	292/7206	0.0147818270356
ko04722	Neurotrophin signaling pathway	3/24	160/7206	0.0154424515691
ko04725	Cholinergic synapse	3/24	160/7206	0.0154424515691
ko04071	Sphingolipid signaling pathway	3/24	162/7206	0.0159630258235
ko05418	Fluid shear stress and atherosclerosis	3/24	173/7206	0.0190040628104
ko05161	Hepatitis B	3/24	173/7206	0.0190040628104
ko04371	Apelin signaling pathway	3/24	177/7206	0.0201849374254
ko05200	Pathways in cancer	5/24	492/7206	0.0209153238243
ko04210	Apoptosis	3/24	180/7206	0.0210969788769
ko04150	mTOR signaling pathway	3/24	184/7206	0.0223482861361
ko04060	Cytokine-cytokine receptor interaction	3/24	191/7206	0.0246351929744
ko05014	Amyotrophic lateral sclerosis (ALS)	2/24	74/7206	0.0248177462142
ko01524	Platinum drug resistance	2/24	76/7206	0.0260815144143
ko04072	Phospholipase D signaling pathway	3/24	197/7206	0.0266938990313
ko05130	Pathogenic Escherichia coli infection	2/24	77/7206	0.0267231458888
ko04370	VEGF signaling pathway	2/24	77/7206	0.0267231458888
ko04062	Chemokine signaling pathway	3/24	201/7206	0.0281168937657
ko04721	Synaptic vesicle cycle	2/24	80/7206	0.0286864744451
ko05230	Central carbon metabolism in cancer	2/24	81/7206	0.029353575651
ko05131	Shigellosis	2/24	82/7206	0.0300269300527
ko04213	Longevity regulating pathway - multiple species	2/24	86/7206	0.0327819773291
ko05210	Colorectal cancer	2/24	86/7206	0.0327819773291
ko05323	Rheumatoid arthritis	2/24	89/7206	0.0349117238807
ko04920	Adipocytokine signaling pathway	2/24	89/7206	0.0349117238807
ko05120	Epithelial cell signaling in Helicobacter pylori infection	2/24	92/7206	0.0370945433703
ko04151	PI3K-Akt signaling pathway	4/24	390/7206	0.037998330572
ko05211	Renal cell carcinoma	2/24	96/7206	0.0400855037608
ko04650	Natural killer cell mediated cytotoxicity	2/24	97/7206	0.0408473396355
ko05132	Salmonella infection	2/24	98/7206	0.0416147291125
ko01521	EGFR tyrosine kinase inhibitor resistance	2/24	106/7206	0.0479487750659